HR Execs on the Move

Orbus Therapeutics

www.orbustherapeutics.com

 
Orbus Therapeutics is dedicated to developing products that treat rare diseases for which there are few, if any, effective therapies. The company’s product candidate in development is eflornithine in an oral solution. Eflornithine is a novel cytostatic agent, which Orbus Therapeutics is developing for the treatment of patients with anaplastic glioma (AG), or Grade 3 glioma, a rare form of central nervous system cancer. Eflornithine irreversibly inhibits ornithine decarboxylase (ODC), a key enzyme in mammalian polyamine biosynthesis that is up-regulated in various types of cancer. Orbus Therapeutics intends to develop and commercialize eflornithine in North America.
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Similar Companies

Med-Response Inc

Med-Response Inc is a Bluefield, WV-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Aspen Hope Center

The Aspen Hope Center is a mental health organization that provides immediate contact to clinical professionals 24/7, information and referral to local mental health services, crisis intervention with a mobile crisis team 24/7, community education abou...

Health Forum

Health Forum is a Chicago, IL-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Emergency Ambulance Service

Emergency Ambulance Service is a Brea, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Savoy Associates

Savoy Associates is a Trenton, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.